Literature DB >> 2390066

Evidence that enzyme-generated aromatic Michael acceptors covalently modify the nucleotide-binding site of 3 alpha-hydroxysteroid dehydrogenase.

J W Ricigliano1, T M Penning.   

Abstract

The non-steroidal allylic and acetylenic alcohols 1-(4'-nitrophenyl)prop-2-en-1-ol (I) and 1-(4'-nitrophenyl)prop-2-yn-1-ol (II) are oxidized by homogeneous 3 alpha-hydroxysteroid dehydrogenase to the corresponding alpha beta-unsaturated ketones 1-(4'-nitrophenyl)prop-2-en-1-one (III) and 1-(4'-nitrophenyl)prop-2-yn-1-one (IV), which then inactivate the enzyme selectively with high affinity; low effective partition ratios are observed for the parent alcohols [Ricigliano & Penning (1989) Biochem. J. 262, 139-149]. Inactivation of 3 alpha-hydroxysteroid dehydrogenase by compound (I) displays an NAD+ concentration optimum. Scavenging experiments indicate that the enzyme-generated inactivators (III) and (IV) alkylate the enzyme via a release-and-return mechanism. Several lines of evidence suggest that compounds (III) and (IV) covalently modify the NAD(P)(+)-binding site. First, micromolar concentrations of NAD(P)H offer substantial protection against enzyme inactivation mediated by Michael acceptors (III) and (IV). In these protection studies Kd measurements for NAD(P)H approached those measured by fluorescence titration of free enzyme. Secondly, under initial-velocity conditions compounds (III) and (IV) act essentially as competitive inhibitors of NAD+ binding, and as mixed competitive or non-competitive inhibitors against androsterone binding. Thirdly, enzyme inactivated with either compound (III) or compound (IV) fails to bind to NAD+ affinity columns (e.g. Affi-gel Blue). Under the same conditions of chromatography native enzyme and enzyme affinity-labelled at the steroid-binding site with 17 beta-bromoacetoxy-5 alpha-dihydrotestosterone is retained on the affinity column. A kinetic scheme that represents the inactivation of the homogeneous dehydrogenase by the enzyme-generated alkylators (III) and (IV) is presented.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2390066      PMCID: PMC1131651          DOI: 10.1042/bj2690749

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  14 in total

1.  The determination of enzyme inhibitor constants.

Authors:  M DIXON
Journal:  Biochem J       Date:  1953-08       Impact factor: 3.857

2.  Affinity labeling of steroid binding sites. Synthesis of 16 -bromoacetoxyprogesterone and its use for affinity labeling of 20 -hydroxysteroid dehydrogenase.

Authors:  F Sweet; F Arias; J C Warren
Journal:  J Biol Chem       Date:  1972-06-10       Impact factor: 5.157

3.  Reaction mechanism of 20 beta-hydroxysteroid dehydrogenase determined by equilibrium rate exchange.

Authors:  G Betz; P Taylor
Journal:  Arch Biochem Biophys       Date:  1970-03       Impact factor: 4.013

4.  Reaction mechanism and stereospecificity of 20 beta-hydroxysteroid dehydrogenase.

Authors:  G Betz; J C Warren
Journal:  Arch Biochem Biophys       Date:  1968-12       Impact factor: 4.013

5.  Affinity labeling of steroid binding sites. Study of the active site of 20-beta-hydroxysteroid dehydrogenase with 6-beta- and 11 alpha-bromoacetoxyprogesterone.

Authors:  F Arias; F Sweet; J C Warren
Journal:  J Biol Chem       Date:  1973-08-25       Impact factor: 5.157

6.  Affinity labeling of steroid binding sites. Synthesis of cortisone 21-iodoacetate and study of 20 beta-hydroxysteroid dehydrogenase.

Authors:  M Ganguly; J C Warren
Journal:  J Biol Chem       Date:  1971-06-10       Impact factor: 5.157

7.  Purification and properties of a 3 alpha-hydroxysteroid dehydrogenase of rat liver cytosol and its inhibition by anti-inflammatory drugs.

Authors:  T M Penning; I Mukharji; S Barrows; P Talalay
Journal:  Biochem J       Date:  1984-09-15       Impact factor: 3.857

8.  Affinity labeling of steroid binding sites. Study of the active site of 20beta-hydroxysteroid dehydrogenase with 2alpha-bromoacetoxyprogesterone and 11alpha-bromacetoxyprogesterone.

Authors:  R C Strickler; F Sweet; J C Warren
Journal:  J Biol Chem       Date:  1975-10-10       Impact factor: 5.157

9.  Inactivation of Streptomyces hydrogenans 20 beta-hydroxysteroid dehydrogenase by an enzyme-generated ethoxyacetylenic ketone in the presence of a thiol.

Authors:  D F Covey; P C McMullan; A J Weaver; W W Chien
Journal:  Biochemistry       Date:  1986-11-18       Impact factor: 3.162

10.  Mechanism-based inactivation of 17 beta,20 alpha-hydroxysteroid dehydrogenase by an acetylenic secoestradiol.

Authors:  R J Auchus; D F Covey
Journal:  Biochemistry       Date:  1986-11-18       Impact factor: 3.162

View more
  3 in total

1.  Mechanistic studies of morphine dehydrogenase and stabilization against covalent inactivation.

Authors:  E H Walker; C E French; D A Rathbone; N C Bruce
Journal:  Biochem J       Date:  2000-02-01       Impact factor: 3.857

2.  Three-dimensional structure of rat liver 3 alpha-hydroxysteroid/dihydrodiol dehydrogenase: a member of the aldo-keto reductase superfamily.

Authors:  S S Hoog; J E Pawlowski; P M Alzari; T M Penning; M Lewis
Journal:  Proc Natl Acad Sci U S A       Date:  1994-03-29       Impact factor: 11.205

3.  The kinetic mechanism catalysed by homogeneous rat liver 3 alpha-hydroxysteroid dehydrogenase. Evidence for binary and ternary dead-end complexes containing non-steroidal anti-inflammatory drugs.

Authors:  L J Askonas; J W Ricigliano; T M Penning
Journal:  Biochem J       Date:  1991-09-15       Impact factor: 3.857

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.